Search IPOs
Subscription Status · Dec 31 – Jan 02, 2026 · ₹85–90
Modern Diagnostic & Research Centre IPO subscribed 376.90 times — as of Jan 02, 2026
The Modern Diagnostic & Research Centre IPO subscription has recorded exceptional investor demand with an overall subscription of 376.90× as of Jan 02, 2026, indicating that investors applied for 376.90 times the number of shares on offer. All investor categories — institutional, HNI, and retail — have participated actively, making this one of the closely watched IPO openings.
As of January 02, 2026
| Category | Shares Offered | Shares Bid For | Times Subscribed | Applications |
|---|---|---|---|---|
|
QIB
Qualified Institutional Buyers
|
782,400 | 151,400,000 |
193.51×
|
— |
|
NII
Non-Institutional Investors
|
585,600 | 411,139,200 |
702.08×
|
— |
|
bNII
Bids above ₹10L
|
393,600 | 336,852,800 |
855.83×
|
— |
|
sNII
Bids below ₹10L
|
192,000 | 74,286,400 |
386.91×
|
— |
|
Retail
Retail Individual Investors
|
1,363,200 | 466,844,800 |
342.46×
|
— |
|
Total
|
2,731,200 | 1,029,384,000 |
376.90×
|
— |
How subscription built up across investor categories over time
Snapshot of each day's bidding activity
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 782,400 | 151,400,000 | 193.51× | — |
| NII | 585,600 | 411,139,200 | 702.08× | — |
| bNII | 393,600 | 336,852,800 | 855.83× | — |
| sNII | 192,000 | 74,286,400 | 386.91× | — |
| Retail | 1,363,200 | 466,844,800 | 342.46× | — |
| Total | 2,731,200 | 1,029,384,000 | 376.90× | — |
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 782,400 | 6,998,400 | 8.94× | — |
| bNII | 393,600 | 24,961,600 | 63.42× | — |
| sNII | 192,000 | 6,201,600 | 32.30× | — |
| Individual Investors | 1,363,200 | 46,140,800 | 33.85× | — |
| Anchor | 1,161,600 | 1,161,600 | 1.00× | — |
| Others | 206,400 | 206,400 | 1.00× | — |
| Total | 2,145,600 | 53,139,200 | 24.77× | — |
As of January 02, 2026, the Modern Diagnostic & Research Centre IPO has been subscribed 376.90 times overall. The IPO is fully subscribed with strong investor demand indicating extremely high interest.
The Modern Diagnostic & Research Centre IPO subscription window was open from December 31, 2025 to January 02, 2026. Investors could apply through their demat account or ASBA facility.
The Modern Diagnostic & Research Centre IPO has a price band of ₹85 to ₹90 per share, with a lot size of 1,600 shares. Minimum retail investment: ₹136,000 (lower band) or ₹144,000 (upper band).
The QIB category has been subscribed 193.51 times. QIBs were offered 782,400 shares. Strong QIB subscription indicates high institutional confidence.
Retail investors subscribed 342.46 times. Retail was offered 1,363,200 shares. High retail subscription reflects strong small-investor interest.
Overall NII: 702.08×. bNII (>₹10L): 855.83×, sNII (<₹10L): 386.91×. NII includes HNIs and corporate entities investing above ₹2 lakh.
Basis of allotment is on January 05, 2026. Check via the registrar's website — MUFG Intime India Pvt.Ltd using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.
Modern Diagnostic & Research Centre IPO is expected to list on January 07, 2026. Shares will list on BSE SME platform. Allotted shares are credited to your demat account 1 business day before listing.
A subscription multiple of 376.90× means investors have bid for 376.90 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares — allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.
Based on the current retail subscription of 342.46×, the estimated allotment probability for retail investors is Very Low. Only 1 lot likely via lottery if selected. Retail allotment in oversubscribed IPOs is done by computerised lottery — each valid application has an equal probability regardless of the number of lots applied for.
You can apply for Modern Diagnostic & Research Centre IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from Dec 31 to Jan 02, 2026.
The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Modern Diagnostic & Research Centre IPO GMP data, check the IPO Rise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price — use it only as a sentiment signal alongside official subscription data.
The Modern Diagnostic & Research Centre IPO subscription tracks how many times each investor category has subscribed relative to their reserved quota. As of Jan 02, 2026, the overall subscription stands at 376.90× — Massively Oversubscribed.
QIBs include domestic mutual funds, FIIs/FPIs, banks, insurance companies, and SEBI-registered venture capital funds. They are allocated up to 50% of the net offer (75% for SME IPOs). For Modern Diagnostic & Research Centre IPO, QIB subscription is at 193.51×. High QIB subscription signals strong institutional conviction and is considered a positive indicator for post-listing performance.
NIIs are high-net-worth individuals (HNIs) and corporate bodies applying for more than ₹2 lakh. SEBI further divides this into bNII (bids above ₹10 lakh) and sNII (bids between ₹2–10 lakh), each with a separate allotment bucket. For Modern Diagnostic & Research Centre IPO: bNII at 855.83×, sNII at 386.91×. Very high NII subscription (>50×) often signals leveraged HNI bidding, suggesting a strong listing expectation.
Retail investors apply for up to ₹2 lakh. They are reserved 35% of the net offer (in most mainboard IPOs). If oversubscribed, allotment is via computerised lottery — each applicant (regardless of lot count) has an equal probability. Modern Diagnostic & Research Centre IPO retail subscription: 342.46×. With 342.46× retail subscription, allotment is lottery-based.
Price band: ₹85–₹90 per share. Lot size: 1,600 shares. Minimum retail investment at upper band: ₹144,000. Applications must be in multiples of 1,600 shares.
Stock exchanges (BSE/NSE) publish subscription data multiple times a day during the subscription window. The figures shown here represent the latest available snapshot. "Shares Offered" is the quota reserved for each category; "Shares Bid For" is the total demand received; "Times Subscribed" is the ratio of demand to supply.
Subscription Opens Done
Dec 31, 2025Subscription Closes Done
Jan 02, 2026Basis of Allotment Done
Jan 05, 2026Listing on BSE Done
Jan 07, 2026Only 1 lot likely via lottery if selected. Based on retail subscription of 342.46×.
Retail allotment in oversubscribed IPOs is done by computerised lottery — each valid application has equal odds regardless of lot size applied.
Share Subscription Card
Download a branded image to share on WhatsApp, Twitter, or Telegram
Higher subscription = lower allotment probability. Progress bars compare each category relative to the highest-subscribed category.